Get started
Author

Jiahan Ke

Observed name: Jia-han Ke
ORCID: 0009-0007-1573-3169
Observed ORCID: 0009-0007-1573-3169
OpenAlex ID: A5018488302
The Imbalance of p53–Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin‐Challenged Cardiomyocytes
2023 · Jianan Pan, Weiyao Xiong, et al. · Advanced Science · 73
Diabetic Cardiomyopathy: A Brief Summary on Lipid Toxicity
2022 · Jiahan Ke, Jianan Pan, et al. · ESC Heart Failure · 62
PDF
Targeting Rab7‐Rilp Mediated Microlipophagy Alleviates Lipid Toxicity in Diabetic Cardiomyopathy
2024 · Jiahan Ke, Jianan Pan, et al. · Advanced Science · 32
Secretion of miRNA-326-3p by senescent adipose exacerbates myocardial metabolism in diabetic mice
2022 · Hao Lin, Xiaonan Chen, et al. · Journal of Translational Medicine · 21
PDF
Hydrogen sulfide alleviates heart failure with preserved ejection fraction in mice by targeting mitochondrial abnormalities via PGC-1α
2023 · Shuying Huang, Xiaonan Chen, et al. · Nitric Oxide · 15
Global, regional, and national trends in peripheral arterial disease among older adults: findings from the global burden of disease study 2021
2025 · Xiaohan Qiu, Ben Hu, et al. · Aging Clinical and Experimental Research · 11
PDF
Uric acid-lowering therapy with benzbromarone in hypertension with asymptomatic hyperuricemia: a randomized study focusing left ventricular diastolic function
2023 · Jiahan Ke, Jianan Pan, et al. · Current Medical Research and Opinion · 7
Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction
2022 · Jun Gu, Jia-han Ke, et al. · Frontiers in Cardiovascular Medicine · 5
PDF
Cardiotoxicity associated with antineoplastic agents: a pharmacovigilance study based on FDA adverse event reporting system
2025 · Xiaohan Qiu, Qinxiao Li, et al. · Therapeutic Advances in Drug Safety · 4
Protease activated receptor 2 deficiency retards progression of abdominal aortic aneurysms by modulating phenotypic transformation of vascular smooth muscle cells via ERK signaling
2024 · Min Wang, Min Wang, et al. · Experimental Cell Research · 3
Quadruple combination therapy with SGLT2i, GLP-1RA, ARNI and MRA in heart failure with preserved ejection fraction patients with type 2 diabetes mellitus: A prospective and observational cohort study
2025 · Jiahan Ke, Xiaohan Qiu, et al. · Kardiologia Polska · 2
PDF
Preventive Effect of Shenfu Injection on Arrhythmia After Percutaneous Coronary Intervention in Patients With ST‐Segment Elevation Myocardial Infarction: A Prospective Randomized Controlled Trial
2025 · Xiaohan Qiu, Yue Wang, et al. · Cardiovascular Therapeutics · 2
PDF
Global Co-occurrence Patterns of Cancer and Cardiovascular Disease: A Comprehensive Analysis Based on the Global Burden of Disease Study 2021
2026 · Xiaohan Qiu, Ben Hu, et al. · Archives of Medical Science · 1
PDF
SGLT2 inhibitors, GLP-1 Receptor Agonists, and their combination in diabetic cardiomyopathy: A prospective cohort study
2025 · Alian Zhang, Jianying Yu, et al. · Kardiologia Polska · 1
PDF
The C-reactive protein-triglyceride-glucose index and incident heart failure subtypes in stable coronary artery disease and type 2 diabetes after PCI: A prospective cohort study
2026 · Xiaohan Qiu, Jiahan Ke, et al. · Kardiologia Polska
PDF
The Role of Uric Acid in the Pathogenesis of Heart Failure With Preserved Ejection Fraction
2026 · Jie Tan, Jiahan Ke, et al. · Cardiology in Review
Uric Acid-Lowering Therapy with Febuxostat in Patients with Chronic Heart Failure and Hyperuricemia: A Prospective and Observational Cohort Study
2025 · Jiahan Ke, Xiaohan Qiu, et al. · Balkan Medical Journal
PDF
Works count: 17
Citation count: 239
H-index: 7
I10-index: 6
Year
Topic
Type